MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 121 filers reported holding MYOVANT SCIENCES LTD in Q4 2022. The put-call ratio across all filers is 1.67 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $75,455 | +50.9% | 2,799 | +0.8% | 0.00% | – |
| Q3 2022 | $50,000 | +42.9% | 2,778 | -1.2% | 0.00% | – |
| Q2 2022 | $35,000 | -5.4% | 2,811 | +0.7% | 0.00% | – |
| Q1 2022 | $37,000 | -80.0% | 2,791 | -76.4% | 0.00% | – |
| Q4 2021 | $185,000 | -74.1% | 11,849 | -62.7% | 0.00% | – |
| Q3 2021 | $714,000 | -71.6% | 31,801 | -71.2% | 0.00% | – |
| Q2 2021 | $2,517,000 | -38.0% | 110,554 | -43.9% | 0.00% | – |
| Q1 2021 | $4,057,000 | -37.5% | 197,177 | -16.1% | 0.00% | -100.0% |
| Q4 2020 | $6,489,000 | -70.6% | 234,935 | -85.0% | 0.00% | -50.0% |
| Q3 2020 | $22,041,000 | -62.9% | 1,568,769 | -45.6% | 0.00% | -71.4% |
| Q2 2020 | $59,409,000 | +1103.1% | 2,881,140 | +340.5% | 0.01% | +600.0% |
| Q1 2020 | $4,938,000 | -51.3% | 654,006 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $10,150,000 | – | 654,006 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACT CAPITAL MANAGEMENT, LLC | 65,000 | $808,000 | 1.13% |
| Bellevue Group AG | 5,919,639 | $73,581,000 | 1.04% |
| Rhenman & Partners Asset Management AB | 310,000 | $3,853,000 | 0.44% |
| Hennion & Walsh Asset Management, Inc. | 279,335 | $3,472,000 | 0.22% |
| TORRAY INVESTMENT PARTNERS LLC | 81,621 | $1,015,000 | 0.19% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 302,120 | $3,755,000 | 0.14% |
| Virtus ETF Advisers LLC | 22,356 | $278,000 | 0.10% |
| Tarbox Family Office, Inc. | 27,500 | $342,000 | 0.08% |
| BOURGEON CAPITAL MANAGEMENT LLC | 15,200 | $189,000 | 0.05% |
| JANUS HENDERSON GROUP PLC | 5,449,107 | $67,735,000 | 0.05% |